30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Tolmar Therapeutics Inc (atrx)

Track

Stock chart
Ticker: atrx
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
DUNCAN MICHAEL R
VP and General Manager
1 sale — total 153,900 USD
Planned sale 16 Nov 2004
Value US$1,460,865.00 | Price 127.11 | Shares 14,637
Planned sale 11 Nov 2004
Value US$2,563,484.00 | Price 216.25 | Shares 59,171
Planned sale 5 Nov 2004
Value US$310,100.00 | Price 31.01 | Shares 10,000
Planned sale 18 Oct 2004
Value US$24,108.00 | Price 30.14 | Shares 800
Planned sale 18 Oct 2004
Value US$126,567.00 | Price 30.14 | Shares 4,200
Planned sale 11 Oct 2004
Value US$36,468.00 | Price 30.39 | Shares 1,200
Planned sale 11 Oct 2004
Value US$115,482.00 | Price 30.39 | Shares 3,800
Planned sale 5 Oct 2004
Value US$320,190.00 | Price 32.02 | Shares 10,000
Planned sale 16 Sep 2004
Value US$99,396.00 | Price 30.12 | Shares 3,300
Planned sale 16 Sep 2004
Value US$51,204.00 | Price 30.12 | Shares 1,700
Planned sale 13 Sep 2004
Value US$150,000.00 | Price 30.00 | Shares 5,000
Planned sale 7 Sep 2004
Value US$292,100.00 | Price 29.21 | Shares 10,000
Planned sale 16 Aug 2004
Value US$30,110.00 | Price 30.11 | Shares 1,000
Planned sale 16 Aug 2004
Value US$120,440.00 | Price 30.11 | Shares 4,000
Planned sale 11 Aug 2004
Value US$152,650.00 | Price 30.53 | Shares 5,000
Planned sale 5 Aug 2004
Value US$305,700.00 | Price 30.57 | Shares 10,000
Planned sale 19 Jul 2004
Value US$167,500.00 | Price 33.50 | Shares 5,000
Sale 16 Jul 2004
Value US$234,500.00 | Price 33.50 | Shares 7,000
Planned sale 12 Jul 2004
Value US$159,775.00 | Price 31.96 | Shares 5,000
Planned sale 6 Jul 2004
Value US$330,400.00 | Price 33.04 | Shares 10,000
Planned sale 16 Jun 2004
Value US$39,324.00 | Price 32.77 | Shares 1,200
Planned sale 16 Jun 2004
Value US$124,526.00 | Price 32.77 | Shares 3,800
Sale 7 Jun 2004
Value US$284,950.00 | Price 28.50 | Shares 10,000
Sale 17 May 2004
Value US$54,030.00 | Price 27.02 | Shares 2,000
Sale 5 May 2004
Value US$311,620.00 | Price 31.16 | Shares 10,000
Sale 16 Apr 2004
Value US$58,520.00 | Price 29.26 | Shares 2,000
Sale 5 Apr 2004
Value US$263,410.00 | Price 26.34 | Shares 10,000
Buy 19 Mar 2004
Value US$245,300.00 | Price 24.53 | Shares 10,000
Sale 19 Mar 2004
Value US$22,320.00 | Price 24.80 | Shares 900
Sale 19 Mar 2004
Value US$12,500.00 | Price 25.00 | Shares 500
Sale 16 Mar 2004
Value US$36,390.00 | Price 24.26 | Shares 1,500
Sale 15 Mar 2004
Value US$12,615.00 | Price 25.23 | Shares 500
Sale 17 Feb 2004
Value US$13,450.00 | Price 26.90 | Shares 500
Sale 17 Feb 2004
Value US$53,800.00 | Price 26.90 | Shares 2,000
Sale 16 Jan 2004
Value US$50,100.00 | Price 25.05 | Shares 2,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2004-11-16 2004-11-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
14,637 +9.6%
127.11
US$1,460,865 		14,637 +9.6% 127.11 US$1,460,865
2004-11-12 2004-11-11 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
59,171 +22.5%
216.25
US$2,563,484 		59,171 +22.5% 216.25 US$2,563,484
2004-11-08 2004-11-05 PlS Planned sale BETHUNE DAVID R

CEO/Chairman

Executive Director
147 +12.2%
340.15
US$2,416,081 		147 +12.2% 340.15 US$2,416,081
2004-10-19 2004-10-18 PlS Planned sale
DUNCAN MICHAEL R

VP and General Manager
800 -52.8%
30.14
US$24,108 		800 -52.8% 30.14 US$24,108
2004-10-19 2004-10-18 PlS Planned sale
DUNCAN MICHAEL R

VP and General Manager
4,200 -85.5%
30.14
US$126,567 		4,200 -85.5% 30.14 US$126,567
2004-10-12 2004-10-11 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research
1,200 -24.7%
30.39
US$36,468 		1,200 -24.7% 30.39 US$36,468
2004-10-12 2004-10-11 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research
3,800 -43.8%
30.39
US$115,482 		3,800 -43.8% 30.39 US$115,482
2004-10-06 2004-10-05 PlS Planned sale
BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
32.02
US$320,190 		10,000 -6.4% 32.02 US$320,190
2004-09-16 2004-09-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
3,300 -85.7%
30.12
US$99,396 		3,300 -85.7% 30.12 US$99,396
2004-09-16 2004-09-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
1,700 -75.6%
30.12
US$51,204 		1,700 -75.6% 30.12 US$51,204
2004-09-14 2004-09-13 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
5,000 -58.8%
30.00
US$150,000 		5,000 -58.8% 30.00 US$150,000
2004-09-08 2004-09-07 PlS Planned sale BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
29.21
US$292,100 		10,000 -6.4% 29.21 US$292,100
2004-08-16 2004-08-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
1,000 -64.5%
30.11
US$30,110 		1,000 -64.5% 30.11 US$30,110
2004-08-16 2004-08-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
4,000 -87.9%
30.11
US$120,440 		4,000 -87.9% 30.11 US$120,440
2004-08-11 2004-08-11 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
5,000 -58.8%
30.53
US$152,650 		5,000 -58.8% 30.53 US$152,650
2004-08-05 2004-08-05 PlS Planned sale BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
30.57
US$305,700 		10,000 -6.4% 30.57 US$305,700
2004-07-19 2004-07-19 PlS Planned sale
WARREN STEPHEN L

VP R&D and CSO
5,000 -100.0%
33.50
US$167,500 		5,000 -100.0% 33.50 US$167,500
2004-07-19 2004-07-16 S Sale
DUNCAN MICHAEL R

VP and General Manager
7,000 -92.7%
33.50
US$234,500 		7,000 -92.7% 33.50 US$234,500
2004-07-12 2004-07-12 PlS Planned sale
GARRETT J STEVEN

Senior VP Clinical Research
5,000 -41.3%
31.96
US$159,775 		5,000 -41.3% 31.96 US$159,775
2004-07-06 2004-07-06 PlS Planned sale
BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
33.04
US$330,400 		10,000 -6.4% 33.04 US$330,400
2004-06-16 2004-06-16 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
1,200 -14.5%
32.77
US$39,324 		1,200 -14.5% 32.77 US$39,324
2004-06-16 2004-06-16 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
3,800 -34.9%
32.77
US$124,526 		3,800 -34.9% 32.77 US$124,526
2004-06-08 2004-06-07 S Sale BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
28.50
US$284,950 		10,000 -6.4% 28.50 US$284,950
2004-05-17 2004-05-17 S Sale
GARRETT J STEVEN

Senior VP Clinical Research
2,000 -15.5%
27.02
US$54,030 		2,000 -15.5% 27.02 US$54,030
2004-05-10 2004-05-05 S Sale
BETHUNE DAVID R

Chief Executive Officer

Executive Director
10,000 -6.4%
31.16
US$311,620 		10,000 -6.4% 31.16 US$311,620
2004-04-19 2004-04-16 S Sale GARRETT J STEVEN

Sr VP Clincal Research

Officer
2,000 -13.4%
29.26
US$58,520 		2,000 -13.4% 29.26 US$58,520
2004-04-06 2004-04-05 S Sale BETHUNE DAVID R

Chairman and CEO

Executive Director
10,000 -6.4%
26.34
US$263,410 		10,000 -6.4% 26.34 US$263,410
2004-03-22 2004-03-19 B Purchase VUTURO GEORGE J Non-Executive Director
10,000 +61.2%
24.53
US$245,300 		10,000 +61.2% 24.53 US$245,300
2004-03-22 2004-03-19 S Sale YARBOROUGH CODY L

VP Dermatology Division

Officer
900 -81.8%
24.80
US$22,320 		900 -81.8% 24.80 US$22,320
2004-03-22 2004-03-19 S Sale YARBOROUGH CODY L

VP Dermatology Division

Officer
500 -31.2%
25.00
US$12,500 		500 -31.2% 25.00 US$12,500
2004-03-17 2004-03-16 S Sale GARRETT J STEVEN

Sr VP Clinical Research

Officer
1,500 -10.4%
24.26
US$36,390 		1,500 -10.4% 24.26 US$36,390
2004-03-17 2004-03-15 S Sale YARBOROUGH CODY L

VP Dermatology Division

Officer
500 -71.4%
25.23
US$12,615 		500 -71.4% 25.23 US$12,615
2004-02-19 2004-02-17 S Sale YARBOROUGH CODY L

VP Dermatology Division
500 -71.4%
26.90
US$13,450 		500 -71.4% 26.90 US$13,450
2004-02-19 2004-02-17 S Sale GARRETT J STEVEN

Sr VP Clinical Research
2,000 -12.2%
26.90
US$53,800 		2,000 -12.2% 26.90 US$53,800
2004-01-20 2004-01-16 S Sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
2,000 -10.9%
25.05
US$50,100 		2,000 -10.9% 25.05 US$50,100
Explore more

More insider trading research around Tolmar Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America